Oligodendroglioma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
| Line 20: | Line 20: | ||
*[[PET|11C-Methionine PET]] and [[PET|F-18 FDG PET]] studies can be used to differentiate oligodendroglioma from anaplastic oligodendroglioma.<ref name=Radio>Radiographic features of oligodendroglioma. Dr. Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref> | *[[PET|11C-Methionine PET]] and [[PET|F-18 FDG PET]] studies can be used to differentiate oligodendroglioma from anaplastic oligodendroglioma.<ref name=Radio>Radiographic features of oligodendroglioma. Dr. Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref> | ||
*[[Florbetapir (18F)|[18F]-fluorodeoxyglucose]] (FDG) uptake of oligodendroglioma is similar to normal [[white matter]], whereas FDG uptake of [[anaplastic|anaplastic oligodendroglioma]] is similar to normal [[gray matter]]. | *[[Florbetapir (18F)|[18F]-fluorodeoxyglucose]] (FDG) uptake of oligodendroglioma is similar to normal [[white matter]], whereas FDG uptake of [[anaplastic|anaplastic oligodendroglioma]] is similar to normal [[gray matter]]. | ||
===Bone Scan=== | |||
*Most malignant gliomas get metastasized to the bones via the hematogenous spread.<ref name="pmid24212625">{{cite journal| author=Beauchesne P| title=Extra-neural metastases of malignant gliomas: myth or reality? | journal=Cancers (Basel) | year= 2011 | volume= 3 | issue= 1 | pages= 461-77 | pmid=24212625 | doi=10.3390/cancers3010461 | pmc=PMC3756372 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24212625 }} </ref> | |||
*[[Bone scan]] may be performed to detect metastases of malignant oligodendroglioma or anaplastic oligodendroglioma to [[bones]].<ref name="pmid16219856">{{cite journal| author=Al-Ali F, Hendon AJ, Liepman MK, Wisniewski JL, Krinock MJ, Beckman K| title=Oligodendroglioma metastatic to bone marrow. | journal=AJNR Am J Neuroradiol | year= 2005 | volume= 26 | issue= 9 | pages= 2410-4 | pmid=16219856 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16219856 }} </ref> | |||
==References== | ==References== | ||
Revision as of 15:59, 13 October 2015
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma other imaging findings |
|
Risk calculators and risk factors for Oligodendroglioma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Other Imaging Findings
Other imaging studies for oligodendroglioma include:[1][2]
Magnetic Resonance Spectroscopy
- N-acetyl aspartate (NAA) peak is dominant
- Choline-to-creatine ratio of less than 3:1
- Reduction of NAA/creatine ratio
Magnetic Resonance Perfusion
- There is increased "chicken wire" network of vascularity, which results in elevated relative cerebral blood volume (rCBV).[3]
- MR perfusion has a sensitivity of 95% for distinguishing grade II from grade III oligodendrogliomas. rCBV above the threshold of 1.75 demonstrates more rapid tumor progression.
Positron Emission Tomography
- 11C-Methionine PET and F-18 FDG PET studies can be used to differentiate oligodendroglioma from anaplastic oligodendroglioma.[3]
- [18F]-fluorodeoxyglucose (FDG) uptake of oligodendroglioma is similar to normal white matter, whereas FDG uptake of anaplastic oligodendroglioma is similar to normal gray matter.
Bone Scan
- Most malignant gliomas get metastasized to the bones via the hematogenous spread.[4]
- Bone scan may be performed to detect metastases of malignant oligodendroglioma or anaplastic oligodendroglioma to bones.[5]
References
- ↑ Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.
- ↑ Nikaido K, Nihira H, Wakai S, Honmo O, Tsuzuki A (2003). "[A case of oligodendroglioma with temporal lobe epilepsy initially suspected as having paroxymal tachycardia]". No To Hattatsu. 35 (5): 401–5. PMID 13677949.
- ↑ 3.0 3.1 Radiographic features of oligodendroglioma. Dr. Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma
- ↑ Beauchesne P (2011). "Extra-neural metastases of malignant gliomas: myth or reality?". Cancers (Basel). 3 (1): 461–77. doi:10.3390/cancers3010461. PMC 3756372. PMID 24212625.
- ↑ Al-Ali F, Hendon AJ, Liepman MK, Wisniewski JL, Krinock MJ, Beckman K (2005). "Oligodendroglioma metastatic to bone marrow". AJNR Am J Neuroradiol. 26 (9): 2410–4. PMID 16219856.